# OnCo record nct05199272 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05199272/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05199272", "NCT05199272" ;
  schema:name "A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies"@en ;
  schema:description "A phase 1/2 trial of 23ME-00610 in renal cell carcinoma, ovarian cancer, neuroendocrine tumours and small-cell lung cancer, run by 23andMe, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05199272/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05199272> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2021-12-29" ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/sclc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct05199272-cancer-res-commun-2025/> .